Home > Compound List > Product Information
Sertaconazole_Molecular_structure_CAS_99592-32-2)
Click picture or here to close

Sertaconazole

Catalog No. DB01153 Name DrugBank
CAS Number 99592-32-2 Website http://www.ualberta.ca/
M. F. C20H15Cl3N2OS Telephone (780) 492-3111
M. W. 437.7699 Fax (780) 492-1071
Purity Email david.wishart@ualberta.ca
Storage Chembase ID: 1024

SYNONYMS

IUPAC name
1-{2-[(7-chloro-1-benzothiophen-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole
IUPAC Traditional name
sertaconazole
Brand Name
Ertaczo
Synonyms
Sertaconazol [Spanish]
Sertaconazolum [Latin]

DATABASE IDS

PubChem SID 46507290
CAS Number 99592-32-2
PubChem CID 65863

PROPERTIES

Hydrophobicity(logP) 6.2
Solubility Practically insoluble

DETAILS

Description (English)
Item Information
Drug Groups approved
Description Sertaconazole nitrate is an antifungal medication of the imidazole class. It is available as a cream to treat skin infections such as athlete's foot. [Wikipedia]
Indication For the topical treatment of interdigital tinea pedis in immunocompetent patients 12 years of age and older, caused by Trichophyton rubrum, Trichophyton mentagrophytes, and Epidermophyton floccosum.
Pharmacology Sertaconazole is an imidazole/triazole type antifungal agent. Sertaconazole is a highly selective inhibitor of fungal cytochrome P-450 sterol C-14 α-demethylation via the inhibition of the enzyme cytochrome P450 14α-demethylase. This enzyme converts lanosterol to ergosterol, and is required in fungal cell wall synthesis. The subsequent loss of normal sterols correlates with the accumulation of 14 α-methyl sterols in fungi and may be partly responsible for the fungistatic activity of fluconazole. Mammalian cell demethylation is much less sensitive to fluconazole inhibition. Sertaconazole exhibits in vitro activity against Cryptococcus neoformans and Candida spp. Fungistatic activity has also been demonstrated in normal and immunocompromised animal models for systemic and intracranial fungal infections due to Cryptococcus neoformans and for systemic infections due to Candida albicans.
Affected Organisms
Yeast and other fungi
Absorption Bioavailability is negligible.
Protein Binding >99% to plasma
External Links
Wikipedia
RxList
Drugs.com

REFERENCES